Caris Life Sciences's logo

Caris Life Sciences Stock and Valuation

Pharmaceuticals and Biotechnology
Year Founded
1996
Headquarters
Irving, TX
Employees
1,500

Caris Life Sciences Valuation Estimate

Based on UpMarket valuation model
$5.97 billion

Caris Life Sciences Valuation as of Last Funding Round

As of 05/11/21, according to PitchBook Data, Inc.
$7.83 billion

Want to buy Caris Life Sciences stock?

UpMarket has helped our customers invest over $120 million into private markets.

Caris Life Sciences Company Overview

Caris Life Sciences is committed to delivering accurate, high-quality, and comprehensive molecular information to cancer patients as well as oncologists in an effort to advance the use of precision medicine. They are of the opinion that a greater understanding of the disease at the cellular level can lead to improved therapeutic choices and breakthroughs. Caris' Precision Oncology Alliance (POA) is a growing network of renowned cancer centers located all over the world that collaborate to enhance precision oncology and biomarker-driven research. The alliance includes prominent healthcare and research institutions such as Hoag, St. Joseph Health, and Duke Cancer Institute.

Caris Life Sciences Valuation History

Caris Life Sciences Stock Price

The stock price of Caris Life Sciences can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.

For illustrative purposes, however, assuming Caris Life Sciences has issued 250 million shares, at the estimated UpMarket valuation of $5.97 billion, each share of Caris Life Sciences stock would be worth $23.90.

Buy Caris Life Sciences Stock

If you would like to buy shares in Caris Life Sciences, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”

One of our investor relations team members will contact you to discuss Caris Life Sciences stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.

UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Caris Life Sciences as well.

Caris Life Sciences Management

Name Position
David Halbert CEO
Michael Korn CMO
Reagan Tully CMO

Caris Life Sciences Investors

Coatue Management

T. Rowe Price

Fidelity Management & Research

Silver Lake

Canada Pension Plan Investment Board

GIC (Singapore)

TPG

ClearBridge

Caris Life Sciences Related Companies

About UpMarket

UpMarket's mission is to unlock the private markets for individual investors.

We provide access to a range of asset classes and investment strategies that span private equity, hedge funds, crypto, real estate, and other alternative assets.

The problem

Historically, accessing private market investments had these challenges:
  • A large barrier to entry due to high investment minimums
  • Time-intensive because sourcing deals is a lot of work even if you’ve got a great network, and
  • Costly because of investment-related diligence costs, paperwork, and legal fees

The solution

UpMarket works to address these barriers for individual investors by:
  • Offering lower investment minimums
  • Sourcing and conducting diligence on opportunities for investors, empowering them to pick and choose from pre-screened opportunities
  • Making the investment process entirely digital, straightforward, and easy to manage from a single portal
Individuals like you have invested over $120 Million with UpMarket.

UpMarket Investment Curation Process

Upmarket curates and conducts diligence on every investment opportunity we offer.

We review every offering’s strategy, risk management, liquidity management, fees and expenses, valuation methodology, tax matters, as well as the fund’s third-party providers including legal counsel, auditor, administrator, and custodian.

We aim to offer our clients investments from disciplined managers that pursue unique strategies across an array of asset classes.

Our goal is to empower you to build a portfolio that best meets your individual Investment objectives.

Unlock the private markets today, with UpMarket.